Growth and Immune Evasion of Lymph Node Metastasis

Cancer patients with lymph node (LN) metastases have a worse prognosis than those without nodal disease. However, why LN metastases correlate with reduced patient survival is poorly understood. Recent findings provide insight into mechanisms underlying tumor growth in LNs. Tumor cells and their secr...

Full description

Bibliographic Details
Main Authors: Dennis Jones, Ethel R. Pereira, Timothy P. Padera
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-02-01
Series:Frontiers in Oncology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fonc.2018.00036/full
id doaj-35d0e0105a7c472db765ef509b4d1f06
record_format Article
spelling doaj-35d0e0105a7c472db765ef509b4d1f062020-11-24T22:22:20ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2018-02-01810.3389/fonc.2018.00036331782Growth and Immune Evasion of Lymph Node MetastasisDennis Jones0Dennis Jones1Ethel R. Pereira2Ethel R. Pereira3Timothy P. Padera4Timothy P. Padera5Edwin L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, MGH Cancer Center, Massachusetts General Hospital, Boston, MA, United StatesHarvard Medical School, Boston, MA, United StatesEdwin L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, MGH Cancer Center, Massachusetts General Hospital, Boston, MA, United StatesHarvard Medical School, Boston, MA, United StatesEdwin L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, MGH Cancer Center, Massachusetts General Hospital, Boston, MA, United StatesHarvard Medical School, Boston, MA, United StatesCancer patients with lymph node (LN) metastases have a worse prognosis than those without nodal disease. However, why LN metastases correlate with reduced patient survival is poorly understood. Recent findings provide insight into mechanisms underlying tumor growth in LNs. Tumor cells and their secreted molecules engage stromal, myeloid, and lymphoid cells within primary tumors and in the lymphatic system, decreasing antitumor immunity and promoting tumor growth. Understanding the mechanisms of cancer survival and growth in LNs is key to designing effective therapy for the eradication of LN metastases. In addition, uncovering the implications of LN metastasis for systemic tumor burden will inform treatment decisions. In this review, we discuss the current knowledge of the seeding, growth, and further dissemination of LN metastases.http://journal.frontiersin.org/article/10.3389/fonc.2018.00036/fulllymphaticslymph nodetumormetastasisimmunity
collection DOAJ
language English
format Article
sources DOAJ
author Dennis Jones
Dennis Jones
Ethel R. Pereira
Ethel R. Pereira
Timothy P. Padera
Timothy P. Padera
spellingShingle Dennis Jones
Dennis Jones
Ethel R. Pereira
Ethel R. Pereira
Timothy P. Padera
Timothy P. Padera
Growth and Immune Evasion of Lymph Node Metastasis
Frontiers in Oncology
lymphatics
lymph node
tumor
metastasis
immunity
author_facet Dennis Jones
Dennis Jones
Ethel R. Pereira
Ethel R. Pereira
Timothy P. Padera
Timothy P. Padera
author_sort Dennis Jones
title Growth and Immune Evasion of Lymph Node Metastasis
title_short Growth and Immune Evasion of Lymph Node Metastasis
title_full Growth and Immune Evasion of Lymph Node Metastasis
title_fullStr Growth and Immune Evasion of Lymph Node Metastasis
title_full_unstemmed Growth and Immune Evasion of Lymph Node Metastasis
title_sort growth and immune evasion of lymph node metastasis
publisher Frontiers Media S.A.
series Frontiers in Oncology
issn 2234-943X
publishDate 2018-02-01
description Cancer patients with lymph node (LN) metastases have a worse prognosis than those without nodal disease. However, why LN metastases correlate with reduced patient survival is poorly understood. Recent findings provide insight into mechanisms underlying tumor growth in LNs. Tumor cells and their secreted molecules engage stromal, myeloid, and lymphoid cells within primary tumors and in the lymphatic system, decreasing antitumor immunity and promoting tumor growth. Understanding the mechanisms of cancer survival and growth in LNs is key to designing effective therapy for the eradication of LN metastases. In addition, uncovering the implications of LN metastasis for systemic tumor burden will inform treatment decisions. In this review, we discuss the current knowledge of the seeding, growth, and further dissemination of LN metastases.
topic lymphatics
lymph node
tumor
metastasis
immunity
url http://journal.frontiersin.org/article/10.3389/fonc.2018.00036/full
work_keys_str_mv AT dennisjones growthandimmuneevasionoflymphnodemetastasis
AT dennisjones growthandimmuneevasionoflymphnodemetastasis
AT ethelrpereira growthandimmuneevasionoflymphnodemetastasis
AT ethelrpereira growthandimmuneevasionoflymphnodemetastasis
AT timothyppadera growthandimmuneevasionoflymphnodemetastasis
AT timothyppadera growthandimmuneevasionoflymphnodemetastasis
_version_ 1725768791225270272